Plan to be presented Sept. 17, 2014

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

l2007s

Rank: President [?]

Points: 18410 [?]

Votes: 123 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Plan to be presented Sept. 17, 2014

posted on Aug 19, 2014 04:45PM

On July 18, 2014, TPL and the creditors’ committee announced
that a term sheet serving as the basis for a Joint Plan of Reorganization (the “Plan”) has been agreed to with the expectation that the Plan will be presented to
the Bankruptcy Court for approval on September 17, 2014. In the event we are required to provide funding to PDS that is not reciprocated by TPL, our
ownership percentage in PDS will increase and we will have a controlling financial interest in PDS, in which case, we will consolidate PDS in our
consolidated financial statements..